UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 1,274,238 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Omega Healthcare Investors, Inc. (NYSE:OHI) by 328.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,661,964 shares of the real estate investment trust’s stock after buying an additional 1,274,238 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.62% of Omega Healthcare Investors worth $67,642,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. Price T Rowe Associates Inc. MD boosted its holdings in Omega Healthcare Investors by 2.7% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 133,166 shares of the real estate investment trust’s stock valued at $4,218,000 after purchasing an additional 3,466 shares during the period. Tidal Investments LLC boosted its stake in Omega Healthcare Investors by 2.5% during the first quarter. Tidal Investments LLC now owns 14,325 shares of the real estate investment trust’s stock valued at $454,000 after buying an additional 348 shares during the period. Cetera Investment Advisers grew its position in Omega Healthcare Investors by 170.6% during the first quarter. Cetera Investment Advisers now owns 97,866 shares of the real estate investment trust’s stock worth $3,099,000 after buying an additional 61,700 shares in the last quarter. Cetera Advisors LLC bought a new position in Omega Healthcare Investors in the 1st quarter worth about $646,000. Finally, GAMMA Investing LLC raised its holdings in shares of Omega Healthcare Investors by 93.4% in the 2nd quarter. GAMMA Investing LLC now owns 2,446 shares of the real estate investment trust’s stock valued at $84,000 after acquiring an additional 1,181 shares in the last quarter. 65.25% of the stock is currently owned by institutional investors.

Omega Healthcare Investors Price Performance

OHI opened at $39.81 on Tuesday. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.48 and a quick ratio of 6.48. The stock’s 50 day simple moving average is $40.59 and its 200 day simple moving average is $37.46. The firm has a market cap of $10.75 billion, a price-to-earnings ratio of 29.27, a PEG ratio of 1.26 and a beta of 0.99. Omega Healthcare Investors, Inc. has a 1 year low of $27.53 and a 1 year high of $44.42.

Omega Healthcare Investors Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were paid a $0.67 dividend. This represents a $2.68 annualized dividend and a dividend yield of 6.73%. The ex-dividend date of this dividend was Monday, November 4th. Omega Healthcare Investors’s payout ratio is 197.06%.

Analyst Upgrades and Downgrades

OHI has been the subject of several recent analyst reports. Truist Financial boosted their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a report on Wednesday, September 4th. Royal Bank of Canada lifted their price objective on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a report on Monday, November 11th. Berenberg Bank started coverage on shares of Omega Healthcare Investors in a research report on Friday, October 18th. They issued a “buy” rating and a $45.00 target price for the company. BNP Paribas upgraded Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price target on the stock in a research report on Thursday, October 31st. Finally, Scotiabank upped their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a report on Monday, August 26th. Seven analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $40.00.

Insider Activity at Omega Healthcare Investors

In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the transaction, the chief operating officer now owns 100,000 shares of the company’s stock, valued at $4,025,000. This represents a 36.19 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the sale, the chief financial officer now owns 183,076 shares in the company, valued at approximately $7,357,824.44. This represents a 10.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by company insiders.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.